Daniel D. Long,Robert Murray McKinnell,Lan Jiang,Mandy Loo,Kassandra Lepack,Lori Jean Van Orden,Gavin Ogawa
申请号：
US14883856
公开号：
US09669027B2
申请日:
2015.10.15
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention provides compounds of formula (I):wherein the variables are defined in the specification, or a pharmaceutically-acceptable salt thereof, that are inhibitors of replication of the hepatitis C virus. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat hepatitis C viral infections, and processes and intermediates useful for preparing such compounds.
